Calm Before The Storm – But Some Medtechs Already Reflect The Ravages Of COVID-19

Our sales ranking of the top 100 publicly traded medtech manufacturers is COVID-19-affected for a relatively sizeable proportion of companies ̶ those whose reporting periods closed during 2020. The effect of the pandemic on their sales was often significant and gave a foretaste of what the rest of the industry will experience when filing calendar year 2020 accounts.

The first implications of the pandemic became apparent for health care provider systems in countries beyond China at the end January 2020, the global implications were clear by late February, and a pandemic was declared in mid-March